// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

MEDICATION BURDEN AND PATIENT-CENTRED OUTCOMES IN ADULTS WITH ADVANCED CHRONIC KIDNEY DISEASE NOT ON RENAL REPLACEMENT THERAPY.

W. Tesfaye - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

SAFETY AND EFFICACY OF LUMASIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAi THERAPEUTIC, IN ADULT AND PEDIATRIC PATIENTS WITH PRIMARY HYPEROXALURIA TYPE 1

W. van't Hoff - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary hyperoxaluria type 1

ALN-GO1

CLINICAL MANIFESTATIONS AND LONG-TERM OUTCOMES OF IGG4-RELATED KIDNEY AND RETROPERITONEAL INVOLVEMENT IN A UNITED KINGDOM IGG4-RELATED DISEASE COHORT

R. Evans - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immunoglobulin G4 related disease

N/A

INPATIENT AND DAY CASE RENAL BIOPSY COMPLICATION RATES AND TRANSFUSION REQUIREMENTS ACROSS TWO UK TERTIARY TEACHING HOSPITALS

S. BASU - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A RARE CASE: FAMILIAL MULTICENTRIC OSTEOLYSIS WITH NEPHROPATHY TREATED WITH TACROLIMUS

D. MAXTED - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypertension

Tacrolimus

Fixed Dose Steroids as Part of Immunosuppressive Therapy in Idiopathic Membranous Nephropathy A Single Centre Experience

G. RANA - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Membranous glomerulonephritis

Methylprednisolone

Monoclonal antibodies: Saviour of the gut vs an agent of kidney injury!

A. SINGH - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Glomerulonephritis

Adalimumab

A new report of glomerulonephritis associated with the use of Talimogene laherparepvec immunotherapy.

R. Scott - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Glomerulonephritis

Imlygic

Symptomatic Icodextrin Right Pleural Effusion From Suspected Pleuro-peritoneal Communication: The Utility of Simultaneous Biochemical Fingerprint Analysis of Drained Pleural Fluid and Peritoneal Dialysis Fluid

M. Onuigbo - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Dyspnea

Icodextrin

Home Haemodialysis (HHD with low dialysate volume (LDV – The green benefit

S. NAIR - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

THE DIFFERENCE BETWEEN MEASURED AND PRESCRIBED DIALYSATE SODIUM IN HEMODIALYSIS MACHINES

A. Shendi - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Methodology in research of Conservative Care Management of End Stage Renal Disease: Are randomized controlled trials the way forward?

R. ABDULLAH - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

End stage renal disease

N/A

COMPARITIVE ASSESSMENT OF PSYCHOSOCIAL NEEDS OF DIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE AND PREDIALYSIS PATIENTS - A SINGLE CENTRE STUDY

F. Kleemann - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Chronic kidney disease

N/A

A COMPARISON BETWEEN MDRD eGFR AND CREATININE CLEARANCE IN RENAL TRANSPLANT PATIENTS

M. KHANDAKER - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Resurrection of the ISN Video Legacy Project

G. JHAJJ - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

ACUTE KIDNEY INJURY IN SURGICAL PATIENTS WITH NORMAL RENAL FUNCTIONS ON ADMISSION

S. Kar - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute renal failure

N/A

ENORMOUS CLINICAL AND PUBLIC HEALTH BURDEN OF ACUTE KIDNEY INJURY, MORBIDITY AND MORTALITY DUE TO SNAKEBITE ENVENOMING IN MYANMAR

C.A. Peh - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

HERBAL BITTER: A RARE CAUSE OF ACUTE TUBULOINTERSTITIAL NEPHRITIS

M. SRIKANTHARAJAH - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Interstitial nephritis

N/A

EVALUATION OF CARDIOVASCULAR RISK AND ASSOCIATION WITH NOVEL BIOMARKERS ON PATIENTS WITH TYPE 2 DIABETES MELLITUS

G. Da Silva Jr. - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Type 2 diabetes mellitus

N/A

THE ACHIEVEMENT OF THERAPEUTIC GOALS FOR TYPE 2 DIABETES MELLITUS PATIENTS AS A STRATEGY FOR PREVENTING DIABETIC NEPHROPATHY IN PRIMARY CARE SETTING

G. Da Silva Jr. - International Society of Nephrology (ISN) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

N/A

Copyright © 2026. QuantiNova All rights reserved